Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Acquisition adds VGA039, a novel investigational monoclonal antibody
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.